David and Bradley Wells, joint managing directors of Sauflon Pharmaceutical, have left the company. The brothers had held the position in the transition period since the acquisition of Sauflon by CooperVision for $1.2 billion in August 2014. They said that after spending 22 years in the business, they are now heading to new challenges.